KIT and thyroid nodule: Basically, what we propose in this paper is the use of BRAF molecular analysis (after uncertain cytological diagnosis) to assess the malignancy of thyroid nodules in the first place, then the use of KIT model for the indeterminate nodules and at last the use of the 8-gene model to ultimately assess the diagnosis of the nodules that otherwise would remain suspicious (Figure 3).